• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Securities
Stocks in Focus

2 Million Shares Purchased on the Open Market to Boost Shareholder Value… Hantop Inc. Rises for the Second Consecutive Day [Featured Stocks]

Hantop Inc.(002680)’s stock price has hit the daily upper limit for two consecutive trading days. It appears that buying interest is surging following news that the largest shareholder plans to purcha…
  • 2026-08-12 09:12:59
  • Kwon Oh Seok
Issues & Trends

Curiosis Inc. Enters the Organoid Drug Evaluation Market… Signs MOU with Gradiant BioConvergence

#Curiosis Inc., a company specializing in lab automation and live-cell imaging, announced on the 12th that it is expanding its business scope into the field of organoid (PDO)-based drug evaluation. Or…
  • 2026-08-12 09:10:57
  • Kim Hyung-il
Issues & Trends

SAMG ENTERTAINMENT CO.,LTD to Hold Encore Performances of the Show Musical "Princess Catch! Tinipping" in Seoul and Daegu

Global IP content company SAMG ENTERTAINMENT CO.,LTD(419530)(SAMG ENTERTAINMENT CO.,LTD) is set to kick off its nationwide tour in the second half of the year with its show musical “Princess Catch! Ti…
  • 2026-08-12 09:07:04
  • Kwon Oh Seok
Issues & Trends

S2W Inc. Participates in the Production of Interpol’s ‘Africa Cyber Threat Report’

S2W Inc., a big data analytics and artificial intelligence (AI) company, announced on the 12th that it participated as a private-sector partner in the production of the “African Cyberthreat Assessment…
  • 2026-08-12 09:01:12
  • Shin Ha-yeon
Issues & Trends

"Incross Co.,Ltd. Transforms from a Media Agency into an AI Data Intelligence Company"

On the 12th, independent research firm Value Finder assessed that Incross Co.,Ltd.(216050)is undervalued, trading at a P/E ratio of just 5.3x despite holding abundant cash and cash equivalents equival…
  • 2026-08-12 08:54:51
  • Kwon Oh Seok
Issues & Trends

L&C BIO Secures Four-Year Clinical Trial Results for 'Megacarti,' a Knee Cartilage Treatment

L&C Bio ( L&C BIO(290650)), a human tissue-based regenerative medicine company, announced on the 12th that it has secured four-year mid-to-long-term clinical follow-up data for its knee cartilage trea…
  • 2026-08-12 08:42:23
  • Kim Hyung-il
Stock Reports

HANKOOK TIRE & TECHNOLOGY Sees Cost Pressure Ease… Target Price Raised to 88,000 Won ↑—DB Inc.

DB Securities forecasts that HANKOOK TIRE & TECHNOLOGY(161390)will continue to see improved earnings as cost pressures ease and the effects of price hikes take hold. The firm maintained its “Buy (BUY)…
  • 2026-08-12 08:34:12
  • Kim Hyung-il
Stock Reports

NC Sees Growth in Mobile Casual Games, Including 'Just Play'… 'Buy' - Meritz

Meritz Securities announced on the 12th that it is maintaining its “Buy” investment rating and target price of 330,000 won for NCsoftCorporation(036570)(NC). Lee Hyo-jin, an analyst at Meritz S…
  • 2026-08-12 08:10:40
  • Kwon Oh Seok
Stock Reports

"ILJIN ELECTRIC: Target Price Lowered to 108,000 Won… 'Buy' Rating Maintained" - NH

NH INVESTMENT & SECURITIES announced on the 12th that it maintained its “Buy” investment rating for ILJIN ELECTRIC(103590), stating, “Further profitability improvements are expected in the second half…
  • 2026-08-12 07:59:18
  • PARK MIN
Stock Reports

NHN’s Cloud Business Shows Strong Profitability… Target Price Raised by 30%—NH

On the 12th, NH INVESTMENT & SECURITIES raised its target price for NHN(181710)by 29.6% from 54,000 won to 70,000 won, citing the company’s proven high profitability in its cloud business. The firm ma…
  • 2026-08-12 07:51:27
  • Kim Kyung-eun
prev 31 32 33 34 35 36 37 38 39 40 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English